StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) bonds

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$9.01−0.11 (-1.21%)

Close on Nov 13, 2026Market cap $1.25BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$50.73M
$0 due within a year
Net debt
-$382.57M
After $433.30M of cash
Implied interest rate
14.62%
FY2025 interest ÷ average debt
Interest coverage
-39.6×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in COMPASS Pathways's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issued
Amended Loan Agreement–$150.00M
Loan Agreement9.75%$50.00M
Loan Agreement, Term Loan One–$30.00M
Loan Agreement, Term Loan Two–$20.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?